Oral nicotine pouches occupy a peculiar regulatory gray zone — marketed as harm-reduction tools for adult smokers, yet increasingly visible in adolescent and young-adult social circles. Understanding how this age group actually perceives these products matters enormously, because attitude ambivalence — simultaneously recognizing risk while seeing appeal — is a known precursor to initiation in tobacco research.
A nationwide text-message survey of 622 respondents aged 14–24 (mean age 20), conducted in March 2025 via the MyVoice platform, probed awareness, use patterns, perceived risks, and attitudes toward clinical intervention. Personal Zyn use was low at 3%, but peer exposure was strikingly higher at 37%, suggesting the social environment is already saturated well ahead of individual uptake. Qualitative content analysis identified three dominant themes: multi-channel exposure pathways (friends and digital media being primary conduits), a state of ambivalence about use rather than clear opposition or endorsement, and notably, an expressed openness to physician-led screening and counseling — an unusual degree of receptivity in this demographic.
The ambivalence finding carries the most clinical weight. Prior nicotine research consistently shows that mixed attitudes — not simple ignorance — are the psychological terrain where initiation most commonly occurs. Pouches like Zyn deliver nicotine without combustion or visible vapor, making them socially discrete and easier to rationalize as low-risk, even among youth who intellectually acknowledge their addictive potential. The 37% peer-exposure figure is particularly telling: social normalization typically precedes personal adoption by only a few years in substance-use trajectories.
This study is primarily descriptive and qualitative, skewing female and non-Hispanic White, which limits generalizability. Nonetheless, the finding that young people actively want healthcare providers to address ONPs in clinical encounters is actionable intelligence for pediatricians and adolescent medicine specialists — a population that rarely volunteers receptivity to physician guidance on substance use. Incremental in scope, but timely given the rapid market expansion of pouches.